title: Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.
authors.forename: Frank C
authors.initials: FC
authors.lastname: Huvers
authors.forename: Calin
authors.initials: C
authors.lastname: Popa
authors.forename: Mihai G
authors.initials: MG
authors.lastname: Netea
authors.forename: Frank H J
authors.initials: FH
authors.lastname: van den Hoogen
authors.forename: Cees J
authors.initials: CJ
authors.lastname: Tack
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000494:pharmacology*; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D000069285:Infliximab; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab